Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor

被引：4
|
作者：
Robles, Joanna [1 ]
Keskinyan, Vahakn S. [2 ]
Thompson, Matthew [3 ]
Davis, Joseph T. [4 ]
Van Mater, David [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Hematol Oncol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[3] Wake Forest Baptist Hosp, Dept Radiol, Winston Salem, NC USA
[4] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA
来源：
PEDIATRIC HEMATOLOGY AND ONCOLOGY | 2020年 / 37卷 / 05期
关键词：
AGGRESSIVE FIBROMATOSIS; PHASE-II; MANAGEMENT; CHILDREN; SARCOMA; BIOLOGY; TISSUE;
D O I：
10.1080/08880018.2020.1735591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：445 / 449
页数：5
相关论文
共 50 条
  • [31] Immunohistochemical analysis of potential targets in desmoid tumor therapy
    Janegova, A.
    Hlavata, Z.
    Babal, P.
    Janega, P.
    VIRCHOWS ARCHIV, 2012, 461 : S227 - S227
  • [32] Radiation therapy for aggressive fibromatosis (desmoid tumor) - Reply
    Demetri, George D.
    Heinrich, Michael C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) : 3715 - 3715
  • [33] Modulation of celecoxib pharmacokinetics by food in pediatric patients
    Stempak, D
    Gammon, J
    Halton, J
    Champagne, M
    Koren, G
    Baruchel, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (03) : 226 - 228
  • [34] Recurrent aggressive mesenteric desmoid tumor successfully treated with sorafenib: A case report and literature review
    Mastoraki, Aikaterini
    Schizas, Dimitrios
    Vergadis, Chrysovalantis
    Naar, Leon
    Strimpakos, Alexios
    Vailas, Michail G.
    Hasemaki, Natasha
    Agrogiannis, George
    Liakakos, Theodore
    Arkadopoulos, Nikolaos
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2019, 10 (04): : 183 - 191
  • [35] Combination of transarterial therapy with sorafenib for hepatocellular carcinoma.
    Cabrera, R.
    Pannu, D. S.
    Caridi, J.
    Firpi, R.
    Soldevila-Pico, C.
    Morelli, G.
    Clark, V.
    George, T. J.
    Nelson, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma
    Huether, Alexander
    Hoepfner, Michael
    Baradari, Viola
    Schuppan, Detlef
    Scheruebl, Hans
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (09) : 1308 - 1317
  • [37] Pain burden in desmoid tumor patients: A survey of the French Advocacy Group SOS Desmoid
    Rigaux, Philippe
    Lefebvre-Kuntz, Daniele
    Penel, Nicolas
    BULLETIN DU CANCER, 2015, 102 (03) : 213 - 216
  • [38] Regression of Recurrent Respiratory Papillomatosis With Celecoxib and Erlotinib Combination Therapy
    Limsukon, Atikun
    Susanto, Irawan
    Hoo, Guy W. Soo
    Dubinett, Steven M.
    Batra, Raj K.
    CHEST, 2009, 136 (03) : 924 - 926
  • [39] Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models
    Mariniello, Barbara
    Rosato, Antonio
    Zuccolotto, Gaia
    Rubin, Beatrice
    Cicala, Maria Verena
    Finco, Isabella
    Iacobone, Maurizio
    Frigo, Anna Chiara
    Fassina, Ambrogio
    Pezzani, Raffaele
    Mantero, Franco
    ENDOCRINE-RELATED CANCER, 2012, 19 (04) : 527 - 539
  • [40] Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth
    Liu, WM
    Chen, YC
    Wang, W
    Keng, P
    Finkelstein, J
    Hu, DP
    Liang, L
    Guo, M
    Fenton, B
    Okunieff, P
    Ding, I
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S103 - S109
12345